Effectiveness and Safety of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir Patients with Genotype 1 Chronic Hepatitis C Virus Infection: Results from the Spanish Real World Cohort
2016 ◽
Vol 64
(2)
◽
pp. S218-S219
◽
2019 ◽
Vol 70
(1)
◽
pp. e113-e114
◽
2019 ◽
Vol 114
(1)
◽
pp. S599-S600
2008 ◽
Vol 27
(9)
◽
pp. 790-797
◽
2015 ◽
Vol 68
(5)
◽
pp. 543-549
◽